BCL2 and colorectal carcinoma: ω-3 FAs have been found to downregulate the activity of signaling networks that promote CRC, including the Wnt/ß-catenin, MAPK/ERK, PI3K/AKT/Bcl-2, and PI3K/PTEN pathways.